<bill session="114" type="h" number="2547" updated="2015-06-18T04:48:38-04:00">
  <state datetime="2015-05-21">REFERRED</state>
  <status>
    <introduced datetime="2015-05-21"/>
  </status>
  <introduced datetime="2015-05-21"/>
  <titles>
    <title type="short" as="introduced">Surrogate Endpoint Improvement and Utilization Act of 2015</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to provide for the development of accelerated approval development plans for investigational drugs and biological products.</title>
  </titles>
  <sponsor id="400659"/>
  <cosponsors/>
  <actions>
    <action datetime="2015-05-21" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2015-05-22">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="114" type="h" number="6"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
</bill>
